On April 1, the Food and Drug Administration (FDA) urged companies to stop selling all forms of the heartburn drug Zantac after the agency concluded the product could cause cancer due to an agent that builds up when the drug is stored for long periods. The agency also...
FDA discourages Zantac sales over cancer risks
read more
